Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death

61Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glutamate toxicity in nerve cells has been well documented and may play a role in a broad spectrum of neurological and ophthalmic diseases. Recent work in several laboratories has suggested that an apoptotic-like mechanism may be implicated in glutamate toxicity under certain circumstances. We therefore studied the effects of transcriptional and translational inhibition on glutamate-mediated cell death in retinal ganglion cells. We now report that either cycloheximide or actinomycin D can, even when added 2 h after the initial excitotoxic insult, save retinal ganglion cells from low dose glutamate toxicity. However, cycloheximide or actinomycin D are unable to prevent glutamate-mediated death at higher concentrations of excitotoxin. This result indicates that at low doses, the neurotoxic effects of glutamate may develop through an apoptotic-like mechanism. © Rapid Communications of Oxford Ltd.

Cite

CITATION STYLE

APA

Dreyer, E. B., Zhang, D., & Lipton, S. A. (1995). Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death. NeuroReport, 6(6), 942–944. https://doi.org/10.1097/00001756-199504190-00029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free